Chemical inhibitors of Med17 function through various molecular mechanisms to inhibit the protein's role in transcription regulation. Trichostatin A, as a histone deacetylase inhibitor, can alter chromatin structure, which can inhibit Med17 by preventing the mediator complex from properly accessing DNA. Similarly, Selisistat's selective inhibition of Sirtuin 1 (SIRT1) affects the acetylation status of histones and transcription factors, potentially disrupting the assembly or stability of the mediator complex that Med17 is a part of. The action of Flavopiridol on cyclin-dependent kinases, including CDK8 that associates with Med17 in the mediator complex, can lead to the functional inhibition of Med17 by impeding transcription regulation. BIX-01294 and SGC-CBP30 target enzymes involved in histone methylation and acetylation, respectively, thereby potentially affecting the epigenetic markers that guide Med17's activity within the mediator complex.
Moreover, DRB inhibits positive transcription elongation factor b (P-TEFb), which is necessary for the transition into productive elongation, a critical step in transcription where Med17 is involved. Inhibition of P-TEFb can thus inhibit Med17's function in transcriptional elongation. Triptolide targets the XPB subunit of TFIIH, crucial for transcription initiation, again potentially inhibiting Med17 by disrupting the formation of the transcription initiation complex. Roxadustat indirectly affects Med17 by altering transcriptional demands, which may influence the recruitment of the mediator complex. GSK343 and UNC1999, which inhibit EZH2 methyltransferase and both EZH1 and EZH2, respectively, can change gene expression patterns and thereby influence the transcription regulation dynamics where Med17 operates. I-CBP112, like SGC-CBP30, inhibits the bromodomains of CBP/p300, potentially leading to a less active chromatin state and affecting Med17's role in transcription. These inhibitors, through their diverse targets, collectively contribute to the modulation of Med17's function in the transcription process.
SEE ALSO...
Items 51 to 11 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|